STC
TMO icon

Sarah T. Connolly’s Thermo Fisher Scientific TMO Stock Holding History

Sarah T. Connolly’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,254
Closed -$5.19M – 77
2023
Q3 		$5.19M Sell
10,254
-172
-2% -$91.7K 3.43% 3
2023
Q2 		$5.44M Sell
10,426
-18
-0.2% -$9.71K 3.29% 3
2023
Q1 		$6.02M Sell
10,444
-171
-2% -$96.4K 3.82% 3
2022
Q4 		$5.85M Sell
10,615
-3
-0% -$1.59K 3.97% 3
2022
Q3 		$5.38M Sell
10,618
-459
-4% -$257K 3.95% 3
2022
Q2 		$6.02M Sell
11,077
-415
-4% -$228K 4.1% 3
2022
Q1 		$6.79M Buy
11,492
+236
+2% +$136K 3.97% 3
2021
Q4 		$7.51M Buy
11,256
+1,978
+21% +$1.23M 4.19% 3
2021
Q3 		$5.3M Sell
9,278
-377
-4% -$207K 4.36% 2
2021
Q2 		$4.87M Buy
9,655
+57
+0.6% +$26.9K 3.98% 3
2021
Q1 		$4.38M Sell
9,598
-38
-0.4% -$18.1K 3.9% 3
2020
Q4 		$4.49M Buy
+9,636
New +$4.52M 4.1% 3

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sarah T. Connolly's TMO Position: Q4 2023 in Review

Sarah T. Connolly sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 10,254 shares — an estimated $5.19M sold.

Sarah T. Connolly first reported a position in TMO in Q4 2020 and held it in 12 quarters. The position peaked at $7.51M in Q4 2021. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Sarah T. Connolly reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Sarah T. Connolly sold 10,254 Thermo Fisher Scientific shares in Q4 2023, an estimated $5.19M.
  • Sarah T. Connolly first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 12 quarters.
  • Sarah T. Connolly's Thermo Fisher Scientific position peaked at $7.51M in Q4 2021.
  • 2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Sarah T. Connolly's 13F filing for Q4 2023, filed 9 Feb 2024.